European Journal of Clinical Pharmacology

, Volume 44, Supplement 1, pp S7–S9

Cytokine regulation of Group II phospholipase A2 expression in glomerular mesangial cells

  • J. Pfeilschifter
  • H. Mühl
  • W. Pignat
  • F. Märki
  • H. van den Bosch
Article

DOI: 10.1007/BF01428384

Cite this article as:
Pfeilschifter, J., Mühl, H., Pignat, W. et al. Eur J Clin Pharmacol (1993) 44: S7. doi:10.1007/BF01428384

Summary

Phospholipase A2 (PLA2) is believed to play an essential role in inflammatory processes by releasing arachidonic acid from membrane phospholipids for synthesis of important lipid mediators, such as prostaglandins, leukotrienes and platelet activating factor.

We have used glomerular mesangial cells as a model system to study the regulation of PLA2 under inflammatory conditions. Potent pro-inflammatory cytokines, such as interleukin 1 (IL-1) and tumour necrosis factor α (TNFα), as well as agents that increase cellular cAMP levels have been found to increase Group II PLA2 gene expression in a time- and dose-dependent manner.

In all cases cytokine-induced synthesis of PLA2 occurred in parallel with cytokine-stimulated prostaglandin (PG) E2 synthesis. Three important classes of compounds that potently antagonise the stimulatory effect of IL-1, TNFα and cAMP on Group II PLA2 expression in mesangial cells have been identified, namely, glucocorticoids, transforming growth factors (TGF) type-β and platelet-derived growth factor (PDGF). Those agents may act sequentially to protect the kidney from damage resulting from cytokine-stimulated mediator release and the subsequent inflammatory reactions.

Key words

Phospholipase A2Mesangial cellCytokinesinterleukin 1tumour necrosis factor αtransforming growth factorβplatelet-derived growth factorglucocorticoids

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • J. Pfeilschifter
    • 1
  • H. Mühl
    • 1
  • W. Pignat
    • 2
  • F. Märki
    • 2
  • H. van den Bosch
    • 3
  1. 1.Department of Pharmacology, BiocenterUniversity of BasleBaselSwitzerland
  2. 2.Pharmaceuticals DivisionResearch DepartmentGiba-Geigy, BasleSwitzerland
  3. 3.Centre for Biomembranes and Lipid EnzymologyUtrechtThe Netherlands